These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 15359787)

  • 1. [Involvement of dendritic cell dysfunction in the persistence of hepatitis C virus infection].
    Kanto T; Hayashi N
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):170-4. PubMed ID: 15359787
    [No Abstract]   [Full Text] [Related]  

  • 2. [Relationship between the dynamics of cytokines and the phenotypes of the disease in chronic HCV infection].
    Okumura A; Kakumu S
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):164-9. PubMed ID: 15359786
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic hepatitis C: virologic and immunologic aspects].
    Moriya K; Koike K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):405-7. PubMed ID: 15359831
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease.
    Gigi E; Raptopoulou-Gigi M; Kalogeridis A; Masiou S; Orphanou E; Vrettou E; Lalla TH; Sinakos E; Tsapas V
    J Viral Hepat; 2008 Feb; 15(2):145-54. PubMed ID: 18184198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-viral immune responses against hepatitis C virus].
    Imawari M
    Uirusu; 2002 Jun; 52(1):151-6. PubMed ID: 12227166
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunomodulating effect of HCV during the development of chronic hepatitis C: toward new therapeutic approaches].
    Stoll-Keller F; Schvoerer E; Thumann C; Navas MC; Aubertin AM
    Bull Acad Natl Med; 2003; 187(6):1147-60; discussion 1160-1. PubMed ID: 14978874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus (HCV): a review of immunological aspects.
    Irshad M; Khushboo I; Singh S; Singh S
    Int Rev Immunol; 2008; 27(6):497-517. PubMed ID: 19065353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of serum cytokines in individuals with HCV infection.
    Fan X; Liu W; Li C
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Jun; 14(2):145-7. PubMed ID: 11503046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of peripheral blood CD4-positive T cells to carcinogenesis in patients with HCV-related chronic hepatitis and liver cirrhosis.
    Matsui T; Nagai H; Sumino Y; Miki K
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):401-6. PubMed ID: 17932673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can we apply the TH1-TH2 paradigm to all lymphocytes?
    Colonna M
    Nat Immunol; 2001 Oct; 2(10):899-900. PubMed ID: 11577341
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum profile of T helper 1 and T helper 2 cytokines in patients with chronic hepatitis C virus infection.
    Abayli B; Canataroğlu A; Akkiz H
    Turk J Gastroenterol; 2003 Mar; 14(1):7-11. PubMed ID: 14593531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus overrides the propensity of human CD40L-activated plasmacytoid dendritic cells to produce Th2 mediators through synergistic induction of IFN-{gamma} and Th1 chemokine production.
    Bendriss-Vermare N; Burg S; Kanzler H; Chaperot L; Duhen T; de Bouteiller O; D'agostini M; Bridon JM; Durand I; Sederstrom JM; Chen W; Plumas J; Jacob MC; Liu YJ; Garrone P; Trinchieri G; Caux C; Brière F
    J Leukoc Biol; 2005 Oct; 78(4):954-66. PubMed ID: 16081597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell regulation of TH1-TH2 development.
    Moser M; Murphy KM
    Nat Immunol; 2000 Sep; 1(3):199-205. PubMed ID: 10973276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence.
    Hiroishi K; Ito T; Imawari M
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1473-82. PubMed ID: 18761560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Th1 and Th2 cytokines in patients with hepatitis C virus infection.
    Fan XG; Liu WE; Li CZ; Wang ZC; Luo LX; Tan DM; Hu GL; Zhang Z
    Mediators Inflamm; 1998; 7(4):295-7. PubMed ID: 9792341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response.
    Bode JG; Brenndörfer ED; Häussinger D
    Biol Chem; 2008 Oct; 389(10):1283-98. PubMed ID: 18713016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell subsets and the regulation of Th1/Th2 responses.
    Maldonado-López R; Moser M
    Semin Immunol; 2001 Oct; 13(5):275-82. PubMed ID: 11502162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered innate immunity in chronic hepatitis C infection: cause or effect?
    Szabo G; Chang S; Dolganiuc A
    Hepatology; 2007 Oct; 46(4):1279-90. PubMed ID: 17886338
    [No Abstract]   [Full Text] [Related]  

  • 19. [Peripheral blood T cell subsets and TH1/TH2 cytokines secretion in children with chronic hepatitis C virus infection].
    Dong Y; Zhang HF; Chen H; Li J; Yang XJ; Zhu SS; Cheng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):26-8. PubMed ID: 17429527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells.
    Langenkamp A; Messi M; Lanzavecchia A; Sallusto F
    Nat Immunol; 2000 Oct; 1(4):311-6. PubMed ID: 11017102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.